The lancet. Diabetes & endocrinology最新文献

筛选
英文 中文
Correction to Lancet Diabetes Endocrinol 2022; 10: 481-83. 《柳叶刀糖尿病内分泌》2022版修正;10: 481 - 83。
IF 44.5
The lancet. Diabetes & endocrinology Pub Date : 2022-09-01 DOI: 10.1016/S2213-8587(22)00194-2
{"title":"Correction to Lancet Diabetes Endocrinol 2022; 10: 481-83.","authors":"","doi":"10.1016/S2213-8587(22)00194-2","DOIUrl":"https://doi.org/10.1016/S2213-8587(22)00194-2","url":null,"abstract":"","PeriodicalId":519532,"journal":{"name":"The lancet. Diabetes & endocrinology","volume":" ","pages":"e9"},"PeriodicalIF":44.5,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40659439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Second brain tumours after pituitary irradiation: lower risk than once thought. 垂体照射后的第二次脑瘤:风险比以前认为的要低。
IF 44.5
The lancet. Diabetes & endocrinology Pub Date : 2022-08-01 Epub Date: 2022-07-01 DOI: 10.1016/S2213-8587(22)00171-1
Luigi Maione, Philippe Chanson
{"title":"Second brain tumours after pituitary irradiation: lower risk than once thought.","authors":"Luigi Maione, Philippe Chanson","doi":"10.1016/S2213-8587(22)00171-1","DOIUrl":"https://doi.org/10.1016/S2213-8587(22)00171-1","url":null,"abstract":"","PeriodicalId":519532,"journal":{"name":"The lancet. Diabetes & endocrinology","volume":" ","pages":"552-554"},"PeriodicalIF":44.5,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40557390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perceptions of alternative methods of insulin storage: an ethical dilemma. 胰岛素储存替代方法的认知:一个伦理困境。
IF 44.5
The lancet. Diabetes & endocrinology Pub Date : 2022-08-01 DOI: 10.1016/S2213-8587(22)00190-5
Arunkumar R Pande, Ashwani Kumar Thakur
{"title":"Perceptions of alternative methods of insulin storage: an ethical dilemma.","authors":"Arunkumar R Pande, Ashwani Kumar Thakur","doi":"10.1016/S2213-8587(22)00190-5","DOIUrl":"https://doi.org/10.1016/S2213-8587(22)00190-5","url":null,"abstract":"","PeriodicalId":519532,"journal":{"name":"The lancet. Diabetes & endocrinology","volume":" ","pages":"558"},"PeriodicalIF":44.5,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40529976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Impact of BMI on COVID-19 vaccine effectiveness. BMI对COVID-19疫苗有效性的影响
IF 44.5
The lancet. Diabetes & endocrinology Pub Date : 2022-08-01 Epub Date: 2022-07-01 DOI: 10.1016/S2213-8587(22)00170-X
Annelies Wilder-Smith, Annika Frahsa
{"title":"Impact of BMI on COVID-19 vaccine effectiveness.","authors":"Annelies Wilder-Smith, Annika Frahsa","doi":"10.1016/S2213-8587(22)00170-X","DOIUrl":"https://doi.org/10.1016/S2213-8587(22)00170-X","url":null,"abstract":"","PeriodicalId":519532,"journal":{"name":"The lancet. Diabetes & endocrinology","volume":" ","pages":"551-552"},"PeriodicalIF":44.5,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246480/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40557393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Banning junk food ads: commitment waning in the UK? 禁止垃圾食品广告:英国承诺减弱?
IF 44.5
The lancet. Diabetes & endocrinology Pub Date : 2022-08-01 Epub Date: 2022-06-22 DOI: 10.1016/S2213-8587(22)00185-1
Talha Burki
{"title":"Banning junk food ads: commitment waning in the UK?","authors":"Talha Burki","doi":"10.1016/S2213-8587(22)00185-1","DOIUrl":"https://doi.org/10.1016/S2213-8587(22)00185-1","url":null,"abstract":"","PeriodicalId":519532,"journal":{"name":"The lancet. Diabetes & endocrinology","volume":" ","pages":"559"},"PeriodicalIF":44.5,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40398703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to Lancet Diabetes Endocrinol 2022; 10: 407-17. 《柳叶刀糖尿病内分泌》2022版修正;10: 407 - 17所示。
IF 44.5
The lancet. Diabetes & endocrinology Pub Date : 2022-08-01 Epub Date: 2022-06-22 DOI: 10.1016/S2213-8587(22)00169-3
{"title":"Correction to Lancet Diabetes Endocrinol 2022; 10: 407-17.","authors":"","doi":"10.1016/S2213-8587(22)00169-3","DOIUrl":"https://doi.org/10.1016/S2213-8587(22)00169-3","url":null,"abstract":"","PeriodicalId":519532,"journal":{"name":"The lancet. Diabetes & endocrinology","volume":" ","pages":"e8"},"PeriodicalIF":44.5,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40398704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What's preventing us from curbing the obesity crisis? 是什么阻碍了我们遏制肥胖危机?
IF 44.5
The lancet. Diabetes & endocrinology Pub Date : 2022-08-01 Epub Date: 2022-07-07 DOI: 10.1016/S2213-8587(22)00195-4
The Lancet Diabetes Endocrinology
{"title":"What's preventing us from curbing the obesity crisis?","authors":"The Lancet Diabetes Endocrinology","doi":"10.1016/S2213-8587(22)00195-4","DOIUrl":"https://doi.org/10.1016/S2213-8587(22)00195-4","url":null,"abstract":"","PeriodicalId":519532,"journal":{"name":"The lancet. Diabetes & endocrinology","volume":" ","pages":"549"},"PeriodicalIF":44.5,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40579210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance. 垂体腺瘤或颅咽管瘤放疗后发生第二脑瘤的风险:一项对3679例长期影像学监测患者的回顾性、多中心、队列研究
IF 44.5
The lancet. Diabetes & endocrinology Pub Date : 2022-08-01 Epub Date: 2022-07-01 DOI: 10.1016/S2213-8587(22)00160-7
Ross Hamblin, Ashley Vardon, Josephine Akpalu, Metaxia Tampourlou, Ioannis Spiliotis, Emilia Sbardella, Julie Lynch, Vani Shankaran, Akash Mavilakandy, Irene Gagliardi, Sara Meade, Claire Hobbs, Alison Cameron, Miles J Levy, John Ayuk, Ashley Grossman, Maria Rosaria Ambrosio, Maria Chiara Zatelli, Narendra Reddy, Karin Bradley, Robert D Murray, Aparna Pal, Niki Karavitaki
{"title":"Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance.","authors":"Ross Hamblin,&nbsp;Ashley Vardon,&nbsp;Josephine Akpalu,&nbsp;Metaxia Tampourlou,&nbsp;Ioannis Spiliotis,&nbsp;Emilia Sbardella,&nbsp;Julie Lynch,&nbsp;Vani Shankaran,&nbsp;Akash Mavilakandy,&nbsp;Irene Gagliardi,&nbsp;Sara Meade,&nbsp;Claire Hobbs,&nbsp;Alison Cameron,&nbsp;Miles J Levy,&nbsp;John Ayuk,&nbsp;Ashley Grossman,&nbsp;Maria Rosaria Ambrosio,&nbsp;Maria Chiara Zatelli,&nbsp;Narendra Reddy,&nbsp;Karin Bradley,&nbsp;Robert D Murray,&nbsp;Aparna Pal,&nbsp;Niki Karavitaki","doi":"10.1016/S2213-8587(22)00160-7","DOIUrl":"https://doi.org/10.1016/S2213-8587(22)00160-7","url":null,"abstract":"<p><strong>Background: </strong>Radiotherapy is a valuable treatment in the management algorithm of pituitary adenomas and craniopharyngiomas. However, the risk of second brain tumour following radiotherapy is a major concern. We assessed this risk using non-irradiated patients with the same primary pathology and imaging surveillance as controls.</p><p><strong>Methods: </strong>In this multicentre, retrospective cohort study, 4292 patients with pituitary adenoma or craniopharyngioma were identified from departmental registries at six adult endocrine centres (Birmingham, Oxford, Leeds, Leicester, and Bristol, UK and Ferrara, Italy). Patients with insufficient clinical data, known genetic predisposition to or history of brain tumour before study entry (n=532), and recipients of proton beam or stereotactic radiotherapy (n=81) were excluded. Data were analysed for 996 patients exposed to 2-dimensional radiotherapy, 3-dimensional conformal radiotherapy, or intensity-modulated radiotherapy, and compared with 2683 controls.</p><p><strong>Findings: </strong>Over 45 246 patient-years, second brain tumours were reported in 61 patients (seven malignant [five radiotherapy, two controls], 54 benign [25 radiotherapy, 29 controls]). Radiotherapy exposure and older age at pituitary tumour detection were associated with increased risk of second brain tumour. Rate ratio for irradiated patients was 2·18 (95% CI 1·31-3·62, p<0·0001). Cumulative probability of second brain tumour was 4% for the irradiated and 2·1% for the controls at 20 years.</p><p><strong>Interpretation: </strong>Irradiated adults with pituitary adenoma or craniopharyngioma are at increased risk of second brain tumours, although this risk is considerably lower than previously reported in studies using general population controls with no imaging surveillance. Our data clarify an important clinical question and guide clinicians when counselling patients with pituitary adenoma or craniopharyngioma on the risks and benefits of radiotherapy.</p><p><strong>Funding: </strong>Pfizer.</p>","PeriodicalId":519532,"journal":{"name":"The lancet. Diabetes & endocrinology","volume":" ","pages":"581-588"},"PeriodicalIF":44.5,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40557391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
World Health Assembly ratifies first global diabetes targets. 世界卫生大会批准首个全球糖尿病目标。
IF 44.5
The lancet. Diabetes & endocrinology Pub Date : 2022-08-01 Epub Date: 2022-07-01 DOI: 10.1016/S2213-8587(22)00192-9
Emma Wilkinson
{"title":"World Health Assembly ratifies first global diabetes targets.","authors":"Emma Wilkinson","doi":"10.1016/S2213-8587(22)00192-9","DOIUrl":"https://doi.org/10.1016/S2213-8587(22)00192-9","url":null,"abstract":"","PeriodicalId":519532,"journal":{"name":"The lancet. Diabetes & endocrinology","volume":" ","pages":"560"},"PeriodicalIF":44.5,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40582236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Management of thyroid nodules. 甲状腺结节的处理。
IF 44.5
The lancet. Diabetes & endocrinology Pub Date : 2022-07-01 DOI: 10.1016/S2213-8587(22)00139-5
Erik K Alexander, Gerard M Doherty, Justine A Barletta
{"title":"Management of thyroid nodules.","authors":"Erik K Alexander,&nbsp;Gerard M Doherty,&nbsp;Justine A Barletta","doi":"10.1016/S2213-8587(22)00139-5","DOIUrl":"https://doi.org/10.1016/S2213-8587(22)00139-5","url":null,"abstract":"<p><p>In the past 30 years, there has been a substantial rise in the detection of thyroid nodules. Largely asymptomatic, thyroid nodules are most often incidental findings that typically pose minimal risk. Data supporting these findings show a rapid rise in the incidental detection of thyroid nodules and cancer, but minimal effect on mortality rates, despite treatment. These data imply that historical approaches to thyroid nodule and cancer care might at times include unnecessary or excessive care. To address this issue, the past decade has witnessed an increasingly conservative approach to nodule management, seeking to individualise care and provide the most focused intervention that leads to favourable outcomes. Benign nodules can be safely monitored with minimal, or long-interval follow-up imaging. Molecular testing should be considered for cytologically indeterminate nodules because of its ability to improve preoperative cancer risk determination and reduce unnecessary surgery. The treatment of biopsy-proven malignant nodules has become increasingly nuanced, since recommendations for near-total thyroidectomy are no longer routine. Hemithyroidectomy is now commonly considered when operative intervention is favoured. Some patients with small volume, isolated cancerous nodules are safely managed non-operatively with active monitoring. In summary, modern management strategies for thyroid nodular disease seek to incorporate the growing amount of available diagnostic and prognostic data, inclusive of demographic, radiological, pathological and molecular findings. Once obtained, an individualised management plan can be effectively formulated.</p>","PeriodicalId":519532,"journal":{"name":"The lancet. Diabetes & endocrinology","volume":" ","pages":"540-548"},"PeriodicalIF":44.5,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40398712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信